Accessibility Menu
Sbc Medical Group logo

Sbc Medical Group(NASDAQ) SBC

Market Cap$318.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-68%
5 YearN/A
1 Year-29%
1 Month-2%
$3.11
-3.12%
-0.10Today
Sbc Medical Group last closing stock price
MetricPriceDate
Last closeUSD 3.102026-07-29
Sbc Medical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.8%USD 2.932026-07-22
1 month-1.59%USD 3.152026-06-29
3 month-6.06%USD 3.302026-04-30
Year to date-28.07%USD 4.312025-12-31
1 year-29.22%USD 4.382025-07-29
3 year-70.05%USD 10.352023-07-28
Since inception-67.77%USD 9.962022-09-26

Sbc Medical Group Financials at a Glance

Market Cap

$318.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$169.34M

Net Income (TTM)

$40.79M

EPS (TTM)

$0.40

P/E Ratio

7.80

Dividend

$0.00

Beta (Volatility)

0.12 (Low)

Price

$3.11

Volume

58,035

Open

$3.21

Previous Close

$3.10

Daily Range

$3.05 - $3.21

52-Week Range

$2.78 - $5.07

Estimated Earnings Date

Aug 12, 2026

SBC News

Foolcom-Featured.png

Sbc Medical Group Posts Weak Fiscal Q2

Motley Fool Markets TeamAug 13, 2025

SBC: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sbc Medical Group

SBC helps cosmetic clinics run smoothly by handling management and support tasks. Its services let clinics focus on patient care, not paperwork. Patients benefit from easier bookings and a wide range of cosmetic treatments.

Clinic Toolkit: What SBC Sells

  • Procurement Services (36.3% of Q2 2025 revenue): Supplies clinics with medical equipment and consumables, supporting daily operations.
  • Franchising (23.1% of Q2 2025 revenue): Licenses the "Shonan Beauty Clinic" brand and business model to partner clinics.
  • Rental Services (15.8% of Q2 2025 revenue): Provides clinics with medical equipment through operating and sales-type leases.
  • Management Services (11.9% of Q2 2025 revenue): Handles marketing, staff recruitment, training, and IT support for clinics.
  • Other Services (12.9% of Q2 2025 revenue): Offers customer loyalty programs, medicine dispensing, and beauty-related services.

Growth Spurts: How SBC Got Here

  • Acquired Aesthetic Healthcare Holdings Pte. Ltd. in Singapore in November 2024.
  • Acquired MB Career Lounge Co. Ltd. in Japan for approximately $13.7 million in July 2025.
  • Expanded into Singapore and the US between 2022 and 2025.
  • Launched a revised fee structure for franchise and management services in April 2025.
  • Repurchased 1,034,308 shares for approximately $5 million from May to July 2025.

Why SBC Stands Out (Without the Hype)

Its network covers 252 clinics in Japan and several abroad. The company’s focus on management support lets clinics concentrate on patient care.

Five Things You Need to Know

  • Q2 2025 revenue was $43,358,847, down 18.35% year-over-year.
  • Procurement revenue rose 16.40% in Q2 2025, while franchising fell 31.58%.
  • Net income for Q2 2025 was $2,458,240, down 86.70% year-over-year.
  • Three customers made up 72% of revenue for the first half of 2025.
  • Cash and cash equivalents were $152.7 million as of June 30, 2025.

Bottom Line

SBC has shifted from direct clinic operations to a service-focused, asset-light model. Its growth relies on supporting clinics, expanding internationally, and adapting to changing fee structures.

AI Generated • Apr 16, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

863

CEO

Yoshiyuki Aikawa, PhD

Website

sbc-holdings.com

Headquarters

Irvine, CA 92618, US

SBC Financials

Key Financial Metrics (TTM)

Gross Margin

70.20%

Operating Margin

36.02%

Net Income Margin

24.09%

Return on Equity

16.38%

Return on Capital

22.50%

Return on Assets

10.51%

Earnings Yield

12.82%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$318.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

102.85M

Volume

58.03K

Avg. Volume

125.34K

Financials (TTM)

Gross Profit

$118.88M

Operating Income

$61.00M

EBITDA

$72.43M

Operating Cash Flow

$46.22M

Capital Expenditure

-$2.16M

Free Cash Flow

$44.06M

Cash & ST Invst.

$167.31M

Total Debt

$51.90M

Sbc Medical Group Performance Analysis

Sbc Medical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 193,542,423N/A
20242024-12-31USD 205,415,5426.1%
20252025-12-31USD 173,607,489-15.5%
Sbc Medical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-8.4%
Q32025-09-30-0.0%
Q42025-12-31-8.7%
Q12026-03-318.8%
Sbc Medical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.04N/A
20232023-12-31USD 0.421039.0%
20242024-12-31USD 0.4815.5%
20252025-12-31USD 0.502.5%
Sbc Medical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-88.7%
Q32025-09-30404.2%
Q42025-12-3116.7%
Q12026-03-31-21.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$43.06M

-9.0%

Gross Profit

$30.04M

-20.4%

Gross Margin

69.75%

N/A

Market Cap

$318.83MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$369.44K

N/A

Employees

863

N/A

Net Income

$11.31M

-47.4%

EBITDA

$19.64M

-38.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$167.31M

+26.7%

Total Debt

$51.90M

+268.1%

Accounts Receivable

$13.09M

-80.5%

Inventory

$2.32M

+37.1%

Long Term Debt

$37.27M

+348.1%

Short Term Debt

$14.63M

+153.1%

Return on Assets

10.51%

N/A

Return on Invested Capital

18.74%

N/A

Free Cash Flow

$8.68M

+639.8%

Operating Cash Flow

$9.23M

+378.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SPIRSpire Global, Inc.
$10.54-7.30%
KNOPKNOT Offshore Partners LP
$10.24+0.39%
ACCOACCO Brands Corporation
$4.33-0.46%
LXFRLuxfer Holdings PLC
$17.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$19.63-0.20%
SKHYSK Hynix
$126.79-0.03%
NOKNokia
$8.41-0.06%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Questions About SBC

What is the current price of Sbc Medical Group?

Sbc Medical Group is trading at $3.10 per share.

What is the 52-week range for Sbc Medical Group?

Over the past 52 weeks, Sbc Medical Group has traded between $2.78 and $5.07.

How much debt does Sbc Medical Group have?

As of the most recent reporting period, Sbc Medical Group reported total debt of $51.90M.

How much cash does Sbc Medical Group have on hand?

Sbc Medical Group reported $167.31M in cash and cash equivalents in its most recent financial results.

What is Sbc Medical Group’s dividend yield?

Sbc Medical Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services